Venezuela has its first outbreak of highly pathogenic influenza A
According to the World Organisation for Animal Health (WOAH), on December 2, 2022, the Venezuelan Ministry of Agriculture reported to WOAH that an outbreak of H5N1 highly pathogenic influenza A occurred in Venezuela.
Looking for chemical products? Let suppliers reach out to you!
You May Interested In
2026-06-27
-
Functional Ingredients Industry Overview
Collection of Markets for Functional Ingredients in Food & Nutrition and Cosmetics.Published in: Mar. 2026
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
Newsun is helping to transform and upgrade food systems at the Food and Agriculture Organization of the United Nations (FAO)
-
PI Industries of India acquires PHC for £32.8 million, targeting $18 billion biopesticide market
-
Bayer launches its new Fluopicolide fungicide in Brazil
-
Brazil's flood crisis: 1 million tons of soybeans are expected to be lost, and wheat production is down 4.3%
-
Brazil's parliament has decided that the Agriculture Ministry is solely responsible for registering pesticides
-
Brazil approved 21 registrations in the first quarter! The pesticide registration process remains lengthy
-
The 22st China Xinjiang International Agriculture Fair will be held on August 8-9
-
UPL has established a global NPP research Center for Natural Plant Production in Mexico
-
Adama: Will expand its coverage of the herbicide Apresa® in Latin America
-
Renaissance Bioscience has patented pioneering RNA production and delivery technologies in China
Recommend Reading
-
FDA Reopens the Raw Manure Debate
-
FDA Sharpens the Dietary Supplement Ingredient Debate
-
FDA and NIH Launch a New Nutrition Science Partnership
-
New Titanium Dioxide Alternative Moves Closer to Market
-
Global Food Policy Shift 60-Day Rice Import Ban in Philippines EU Issues 5 Recalls on Chinese Exports in One Week
-
Noom Launches Compounded Wegovy for Weight Loss at $119 Patients See 15 to 20 Percent Reduction
-
SABIC Q2 Net Income Surges to SAR 500 Million on 3 Percent Sales Rise Board Approves SAR 4.5 Billion Dividend
-
Syndax Q2 Net Loss Widens to $71.8 Million Despite 43 Percent Revenue Surge and New Drug Momentum
-
Vertex Shares Plunge 14.4 Percent After Pain Drug Trial Misses Key Target and Study Halt
-
Cost and Supply Resonance Drives Up Prices—Melamine Market Rises Strongly